Tremfya Injection
Product Images NDC 57894-651

Product Visual Gallery

This gallery contains 85 technical images submitted to the FDA as part of the official labeling for Tremfya (NDC 57894-651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Tremfya 01)

A line graph depicting the percent of subjects over weeks in a clinical study comparing Tremfya (Guselkumab) 100 mg every 8 weeks versus placebo. The x-axis shows time in weeks (0 to 24) and the y-axis shows percent of subjects (0% to 100%). The graph includes two lines: a dashed line with open circles representing placebo subjects, and a solid line with filled triangles representing subjects taking Guselkumab 100 mg q8w. The Guselkumab line shows higher percent response over time compared to placebo.*

FDA Label Image

Figure (Tremfya 02)

TREMFYA 100 mg/mL injection vial label, a human prescription drug containing guselkumab. The label shows dosage form as injection for intravenous use. Manufacturer is Janssen Biotech, Inc. The vial is clear with a white cap and features dosage, usage, and lot information on the label.*

FDA Label Image

Figure (Tremfya 03)

An instructional diagram of a syringe used for TREMFYA (Guselkumab) injection, showing labeled parts including the plunger, safety guard, finger flange, syringe body, viewing window, and needle cover with warnings about handling the plunger and when to remove the needle cover before injection.*

FDA Label Image

Figure (Tremfya 04)

An instructional diagram illustrating the safety features of a prefilled injection syringe for TREMFYA (Guselkumab). It shows labeled parts including the plunger locks, safety guard activation, and needle retraction mechanism, demonstrating how the needle retracts into the syringe body for safe use and disposal.*

FDA Label Image

Figure (Tremfya 04a)

An illustration showing two dosage options for TREMFYA (guselkumab) injection. The first option is 200 mg delivered in one prefilled syringe, and the second option is 400 mg delivered using two prefilled syringes. Each syringe is depicted with a yellow plunger and needle cap.*

FDA Label Image

Figure (Tremfya 05)

An instructional illustration showing a rectangular product box labeled with a medication label. To the upper left is a clock graphic indicating 30 minutes, likely representing a required time duration related to the product.*

FDA Label Image

Figure (Tremfya 06)

An instructional illustration showing four blue adhesive patches applied to an arm, abdomen, and both thighs. The image likely depicts recommended sites for subcutaneous injection or placement of medication patches.*

FDA Label Image

Figure (Tremfya 07)

An instructional illustration showing two steps of hand hygiene: washing hands under running water with soap, and drying hands using a towel or cloth. The images emphasize proper hand cleaning technique.*

FDA Label Image

Figure (Tremfya 08)

An instructional illustration showing a close-up view of a syringe needle setup, highlighting the connection between the needle and the syringe barrel. The image appears to be part of usage instructions for an intravenous injection product.*

FDA Label Image

Figure (Tremfya 09)

An instructional illustration showing a hand holding a syringe with a needle pointing right and a small drop at the needle tip, with a cap or protective cover positioned to the left of the needle. The background is light gray, focusing on injection preparation technique.*

FDA Label Image

Figure (Tremfya 10)

An instructional illustration showing a hand holding a syringe at a 45-degree angle, preparing to inject into a forearm. The diagram emphasizes proper needle angle for intravenous injection.*

FDA Label Image

Figure (Tremfya 11)

An instructional illustration showing two hands preparing an injection syringe, demonstrating the process of drawing medication from a vial or preparing the syringe for intravenous administration.*

FDA Label Image

Figure (Tremfya 12)

An instructional illustration showing the assembly of a syringe and a vial adapter. The image is divided diagonally, with an arrow indicating the connection of the vial adapter to the syringe. It depicts hands holding and preparing the injection device, relevant to intravenous administration of TREMFYA (Guselkumab).*

FDA Label Image

Figure (Tremfya 13)

An instructional illustration showing a pair of hands holding a syringe. It depicts the process of pulling the syringe plunger back, indicated by a blue arrow pointing upward, likely to withdraw medication or air from the syringe barrel.*

FDA Label Image

Figure (Tremfya 14)

An instructional illustration showing a hand holding a prefilled syringe above a biohazard sharps disposal container. The image depicts proper disposal of an injection syringe into the red sharps container, emphasizing safe handling and disposal practices.*

FDA Label Image

Figure (Tremfya 15)

An instructional illustration showing a hand pressing a small cotton ball or gauze pad against skin, likely demonstrating a step in administering an injection or post-injection care for the drug Tremfya (Guselkumab) intravenous injection.*

FDA Label Image

Figure (Tremfya 16)

TREMFYA 100 mg/mL intravenous injection vial label by Janssen Biotech, Inc. The circular label includes the product name, concentration, dosage form, and visible regulatory markings with a blue and white color scheme.*

FDA Label Image

Figure (Tremfya 17)

An instructional illustration showing a white and teal medical injection device with a transparent base. It appears to be designed for intravenous administration, likely associated with TREMFYA (Guselkumab) injection delivery.*

FDA Label Image

Figure (Tremfya 18)

An illustration diagram of an injection device for TREMFYA (guselkumab) showing labeled parts: handle, teal body, window, needle guard, and bottom cap. The diagram visually identifies components of the intravenous injection device used for administering the drug.*

FDA Label Image

Figure (Tremfya 18a)

Illustration showing dosing options of TREMFYA (Guselkumab) injection pens. It depicts a single pen labeled as 200 mg and a pair of pens labeled as 400 mg in total (2 pens). The image visually differentiates quantity and dosage strengths of the injection pens.*

FDA Label Image

Figure (Tremfya 19)

An instructional illustration showing a box labeled "EXP" and a clock highlighting a 30-minute segment, indicating a time-related guidance likely for the TREMFYA (Guselkumab) injection product by Janssen Biotech, Inc.*

FDA Label Image

Figure (Tremfya 20)

An instructional diagram depicting four blue adhesive patches applied to a person's body for intravenous injection sites. The patches are located on the upper arm, abdomen, lower back, and thigh, illustrating potential injection or treatment areas relevant to the intravenous injection route of TREMFYA (Guselkumab).*

FDA Label Image

Figure (Tremfya 21)

An instructional illustration showing two separate hand actions: on the left, a hand being washed with water droplets falling; on the right, a hand pressing down on an injection site or similar area with a finger. The image likely demonstrates proper handwashing and site care related to drug administration.*

FDA Label Image

Figure (Tremfya 22)

An instructional illustration showing a step in the preparation or administration process for an injection. The image depicts a syringe cap or needle cover being removed or positioned, with emphasis on the needle area, likely related to the intravenous injection of Tremfya (Guselkumab). No text or brand information is visible.*

FDA Label Image

Figure (Tremfya 23)

An instructional illustration showing a hand holding a device with an arrow indicating a twisting motion to the left and a downward arrow. The image likely demonstrates how to unlock or activate a medication injection device for the drug TREMFYA (Guselkumab).*

FDA Label Image

Figure (Tremfya 24)

An instructional illustration showing a hand holding a vial or syringe, tilted at a 90-degree angle, likely demonstrating a step in preparing or administering an injection.*

FDA Label Image

Figure (Tremfya 25)

An instructional illustration showing a hand pressing down on a device or cap, with a blue downward arrow indicating the pressing action. The image likely demonstrates a step in the use or activation of an injection device for TREMFYA (Guselkumab) intravenous injection.*

FDA Label Image

Figure (Tremfya 26)

An instructional illustration showing a hand pressing down on a device or cap with a "click" sound indicated, likely demonstrating the activation or opening mechanism of a product component.*

FDA Label Image

Figure (Tremfya 27)

Illustration showing a hand pulling upward on a cap or cover from an injection vial or device, indicated by a blue arrow pointing upward, likely demonstrating how to remove the cap before use.*

FDA Label Image

Figure (Tremfya 28)

An illustration showing a hand holding a used vial or syringe positioned above a red biohazard sharps disposal container with a biohazard symbol on the lid, indicating proper disposal of injection materials.*

FDA Label Image

Figure (Tremfya 29)

An instructional illustration showing a hand pinching or lifting a fold of skin, likely demonstrating proper technique for an injection or subcutaneous administration site preparation.*

FDA Label Image

Figure (Tremfya 30)

Packaging label for Tremfya (guselkumab) injection 100 mg/mL, a single-dose One-Press patient-controlled injector for subcutaneous use only. The label includes dosage instructions, discard warnings, and states no preservatives are in the product. Manufactured by Janssen Biotech, Inc., with labeling emphasizing patient-controlled injector and Rx only status.*

FDA Label Image

Figure (Tremfya 31)

TREMFYA (Guselkumab) injection device shown as a prefilled syringe with clear barrel, teal plunger, and needle cover. The syringe is designed for intravenous administration and is labeled by Janssen Biotech, Inc. No specific dosage or volume markings are visible in the image.*

FDA Label Image

Figure (Tremfya 32)

TREMFYA 100 mg/mL injection vial label showing the proprietary name, generic name Guselkumab, dosage strength, and route as intravenous injection. The label includes information such as concentration, labeler Janssen Biotech, Inc., lot number, expiration date, and storage instructions on a white and blue background.*

FDA Label Image

Figure (Tremfya 33)

Illustration of a syringe labeled with parts relevant to the injection of TREMFYA (guselkumab). It identifies the plunger with a warning not to hold or pull it, the safety guard, finger flange, syringe body below the finger flange, a viewing window, and a needle cover with instructions not to remove it until ready to inject TREMFYA.*

FDA Label Image

Figure (Tremfya 34)

An instructional diagram illustrating the safety mechanism of an injection device. It shows the plunger stopping, activation of the safety guard, and the needle retracting into the body, depicting features that enhance safe needle handling.*

FDA Label Image

Figure (Tremfya 35)

An instructional illustration showing a box with a label and a clock symbol indicating a 30-minute duration. This image likely relates to the preparation or administration timing for TREMFYA (Guselkumab) injection.*

FDA Label Image

Figure (Tremfya 36)

An illustration showing recommended injection sites for an intravenous injection, highlighting the upper arm, abdomen, front thigh, and area near the hip.*

FDA Label Image

Figure (Tremfya 37)

An instructional illustration showing handwashing steps: one hand being rinsed under running water and the other hand using a cloth or towel to dry the skin. The image emphasizes proper hand hygiene technique.*

FDA Label Image

Figure (Tremfya 38)

An instructional diagram showing a close-up view of a syringe with a visible liquid level and measurement marks. The image emphasizes how to properly hold and use the syringe for injection.*

FDA Label Image

Figure (Tremfya 39)

An instructional illustration showing a hand holding a syringe with a drop coming from the needle tip and a needle cap positioned nearby, indicating syringe preparation or injection steps.*

FDA Label Image

Figure (Tremfya 40)

An instructional illustration showing a hand holding a syringe at a 45-degree angle to the skin, demonstrating the proper technique for an intravenous injection of TREMFYA (guselkumab). The diagram emphasizes the angle for correct administration.*

FDA Label Image

Figure (Tremfya 41)

An instructional illustration showing a person holding and preparing a syringe with a needle attached, likely demonstrating the steps to draw or inject medication. The image depicts the hands grasping the syringe barrel and plunger.*

FDA Label Image

Figure (Tremfya 42)

Instructional illustration showing how to operate a syringe device, including how to press the plunger and release the stopper, likely demonstrating the preparation or administration steps for an injection.*

FDA Label Image

Figure (Tremfya 43)

An instructional illustration showing hands holding a syringe filled with medication. The plunger is being pulled back, indicated by a blue upward arrow, demonstrating how to draw medication into the syringe. The illustration is likely intended for use with the intravenous injection of TREMFYA (guselkumab).*

FDA Label Image

Figure (Tremfya 44)

An instructional illustration showing a hand holding a pre-filled syringe of TREMFYA (Guselkumab) injection, about to dispose it into a red biohazard sharps container. The container has a biohazard symbol and an open lid for safe syringe disposal.*

FDA Label Image

Figure (Tremfya 45)

An instructional illustration showing a hand holding a small pad or cloth, pressing or applying it to a surface. The image appears to demonstrate a step in the preparation or administration process for an intravenous injection.*

FDA Label Image

Figure (Tremfya 46)

TREMFYA (Guselkumab) 200 mg/20 mL intravenous injection vial carton. The label indicates this is a prescription drug manufactured by Janssen Biotech, Inc., and the package contains 20 mL of solution at a concentration of 200 mg per 20 mL.*

FDA Label Image

Figure (Tremfya 47)

An instructional illustration showing a hand pushing down on the plunger of an intravenous injection device labeled TREMFYA (guselkumab). The image visually guides the user to press and hold the plunger to administer the injection.*

FDA Label Image

Figure (Tremfya 48)

Packaging label for TREMFYA injection, containing 200 mg/20 mL of Guselkumab. The label includes product information such as the proprietary name TREMFYA, dosage form as injection, intravenous route, and manufacturer Janssen Biotech, Inc. The vial and package details are visible.*

FDA Label Image

Figure (Tremfya 49)

TREMFYA 100 mg/mL injection vial label by Janssen Biotech, Inc. The label clearly shows the proprietary name TREMFYA and the strength 100 mg/mL. It indicates the dosage form as injection and the route of administration as intravenous. Additional regulatory and manufacturing details are visible on the label.*

FDA Label Image

Figure (Tremfya 50)

An instructional diagram showing the components and proper use of an injection device for Tremfya (Guselkumab), including the handle, teal body, window, needle guard, and bottom cap. It highlights the correct pressing of the handle, visibility of the teal body and yellow band, and cautions not to lift the needle guard during injection.*

FDA Label Image

Figure (Tremfya 51)

An instructional illustration showing a clock icon with the text 'WAIT 30 MIN.' above a rectangular box, indicating a waiting period of 30 minutes. The image appears to guide a procedure or step involving a timed wait.*

FDA Label Image

Figure (Tremfya 52)

Packaging label image showing a rectangular box for TREMFYA injection by Janssen Biotech, Inc. The visible part includes the EXP (expiration date) marking on the box, but no strength or dosage details are visible in the image.*

FDA Label Image

Figure (Tremfya 53)

An instructional diagram showing a sitting person with highlighted areas on the upper arm, abdomen, and thigh, indicating preferred injection sites. Text beside the upper arm notes 'Read below,' suggesting accompanying instructions for injection.*

FDA Label Image

Figure (Tremfya 54)

An instructional illustration showing hand hygiene with soap and water on the left, and on the right, a hand holding a syringe with a needle positioned over a vial or injection site, indicating preparation or administration of an injection.*

FDA Label Image

Figure (Tremfya 55)

An illustration showing a syringe with a protective cap and a no-hand symbol, indicating a restriction or caution related to manual handling or use of the syringe. The image likely serves as an instructional graphic related to the injection product TREMFYA (guselkumab).*

FDA Label Image

Figure (Tremfya 56)

An instructional illustration showing a hand holding a vial with a dropper above it, indicating the step of inserting or using the dropper in the vial. A downward arrow emphasizes the motion or action to be performed downward into or on the vial.*

FDA Label Image

Figure (Tremfya 57)

An instructional illustration showing two steps of using a medical injection device. The first step depicts a hand pressing down on the device, indicated by a downward arrow, and the second step shows the hand pressing further to operate or activate the device. This likely demonstrates proper use or administration technique for the injection.*

FDA Label Image

Figure (Tremfya 58)

An instructional illustration showing a hand pressing down on a device or container to produce a 'click' sound, indicating a step in the use of the injection product TREMFYA by Janssen Biotech, Inc.*

FDA Label Image

Figure (Tremfya 59)

An instructional illustration showing a hand gripping a medication vial cap with an upward arrow, indicating the removal of the vial cap or stopper before use.*

FDA Label Image

Figure (Tremfya 60)

Illustration showing a hand discarding a small medical container into a red biohazard sharps disposal container with a biohazard symbol on it. The image emphasizes safe disposal of medical sharps or small containers used in drug injection procedures.*

FDA Label Image

Figure (Tremfya 61)

An illustration showing a hand pressing a cotton ball or pad onto a surface, likely demonstrating a step related to drug injection or administration.*

FDA Label Image

Figure (Tremfya 62)

An instructional diagram depicting a hand gripping a device, likely an injection pen, with a separate small cartridge or component beside it. The illustration visually demonstrates how to hold or position the injection device.*

FDA Label Image

Figure (Tremfya 63)

An illustration icon depicting a medicine vial with a thermometer symbol next to the text "Storage information." This image signifies storage instructions related to the product.*

FDA Label Image

Figure (Tremfya 64)

Instructional diagram showing a prefilled injection pen for TREMFYA (Guselkumab) with labeled parts including a teal needle guard, viewing window, and cap. It illustrates the pen before use (viewing window shows no plunger rod) and after use (viewing window filled by yellow plunger rod). Additional text lists items needed: 1 prefilled pen, alcohol swabs, cotton balls or gauze pads, adhesive bandages, and a sharps container.*

FDA Label Image

Figure (Tremfya 65)

An instructional illustration showing a rectangular box with a label on top, accompanied by a clock image indicating to wait 30 minutes. This diagram likely relates to a step in preparing or handling the medication TREMFYA (Guselkumab) injection.*

FDA Label Image

Figure (Tremfya 66)

An instructional diagram showing a close-up view of a portion of an injection device with a magnified circular inset highlighting the liquid level inside a window, accompanied by an eye symbol indicating the user should visually check the liquid.*

FDA Label Image

Figure (Tremfya 67)

An illustration showing a human figure seated with blue shaded areas on the outer upper arm, abdomen, and front thigh, indicating possible injection sites. The figure has a note pointing to the upper arm area with the text 'Read below,' suggesting additional instructions related to injection site selection.*

FDA Label Image

Figure (Tremfya 68)

An instructional illustration showing hand hygiene steps: one hand is being rinsed or washed with water droplets, while another hand is holding a wipe or tissue to clean a surface or hand. The image depicts cleanliness or sanitization practices, possibly related to preparation before injection or medical procedures.*

FDA Label Image

Figure (Tremfya 69)

An instructional illustration showing the connection of a syringe or injection device tip to a corresponding component, indicated by an arrow pointing leftwards. The image is likely part of administration instructions for TREMFYA (guselkumab) intravenous injection by Janssen Biotech, Inc.*

FDA Label Image

Figure (Tremfya 70)

An instructional illustration depicting a hand pressing down on a device labeled with a window, accompanied by the text '1st CLICK!' and a downward blue arrow, indicating a step in the use of an injection device for TREMFYA (Guselkumab) intravenous injection.*

FDA Label Image

Figure (Tremfya 71)

An instructional illustration showing a hand holding an injection device, demonstrating the action of a second click after 10 seconds, likely part of the administration steps for an intravenous injection.*

FDA Label Image

Figure (Tremfya 72)

An instructional illustration showing the proper eye-level viewing of the solution in the stem of a syringe or injection device. A downward arrow indicates direction, and a line of sight from an eye is aligned with the liquid reservoir for accurate measurement or inspection.*

FDA Label Image

Figure (Tremfya 73)

An instructional illustration showing a hand holding a pen-like injection device vertically above the skin, with a blue arrow pointing upward, indicating the direction for using the device.*

FDA Label Image

Figure (Tremfya 74)

An instructional illustration depicting a hand holding a cotton ball or pad against a surface, demonstrating a step in an injection or medical preparation process.*

FDA Label Image

Figure (Tremfya 75)

An instructional illustration showing a hand disposing of a used injection device into a red sharps disposal container, indicating proper and safe disposal of injection needles or similar medical waste.*

FDA Label Image

Figure (Tremfya 76)

FDA Label Image

Principal Display Panel (100 mg/mL Syringe Carton)

TREMFYA (guselkumab) Injection 100 mg/mL prefilled syringe packaging label for subcutaneous use. The label indicates it is for prescription use only and contains one single-dose prefilled syringe. The manufacturer is Janssen Biotech, Inc. Additional warnings note discarding unused portions and absence of preservatives.*

FDA Label Image

Principal Display Panel (100 mg/mL Syringe Carton)

Packaging label for Tremfya (guselkumab) injection, 100 mg/mL, in a single-dose one-press patient-controlled injector. The label indicates subcutaneous use only and includes manufacturer information for Janssen Biotech, Inc. The label also notes to discard unused portion and that the product contains no preservative.*

FDA Label Image

Principal Display Panel (100 mg/mL Pen Carton)

Packaging label for TREMFYA PEN (guselkumab) Injection 100 mg/mL, a subcutaneous injection presented in a single-dose prefilled pen. The label includes instructions for use and disposal, the Janssen Biotech, Inc. and Johnson & Johnson branding, and specifies the product is for prescription use only. The design features teal, purple, and orange colors with dosage and usage information prominently displayed.*

FDA Label Image

Principal Display Panel (200 mg/20 mL Vial Carton)

Packaging label for TREMFYA (guselkumab) injection, 200 mg/20 mL (10 mg/mL), for intravenous infusion only. The label indicates a single-dose vial, manufactured by Janssen Biotech, Inc. It includes storage instructions, ingredient details, and a barcode.*

FDA Label Image

Principal Display Panel (200 mg/2 mL Pen Carton)

Tremfya PEN (guselkumab) Injection 200 mg/2 mL prefilled pen packaging label. The label indicates it is for subcutaneous use only and contains one single-dose prefilled pen. Manufactured by Janssen Biotech, Inc. and marketed under Johnson & Johnson. Packaging includes instructions to discard unused portion and to dispense the enclosed medication guide to each patient.*

FDA Label Image

Principal Display Panel (200 mg/2 mL Syringe Carton)

TREMFYA 200 mg/2 mL (Guselkumab) injection carton label. This is for a single-dose prefilled syringe intended for subcutaneous use only. The label includes directions to discard unused portions and instructs dispensing the medication guide to patients. The manufacturer is Janssen Biotech, Inc.*

FDA Label Image

Principal Display Panel (200 mg/2 mL Pen Carton)

TREMFYA PEN (guselkumab) injection 200 mg/2 mL in a carton for subcutaneous use only, labeled as an induction pack for Crohn's Disease and Ulcerative Colitis. The packaging contains 2 single-dose prefilled pens and is manufactured by Janssen Biotech, Inc. The label emphasizes dispensing the entire carton as a unit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.